Anti-thymocyte globulin-induced hyperbilirubinemia in patients with myelofibrosis undergoing allogeneic hematopoietic cell transplantation (Q40094493)

17 September 2017

Anti-thymocyte globulin-induced hyperbilirubinemia in patients with myelofibrosis undergoing allogeneic hematopoietic cell transplantation (English)

1 reference

bilirubin metabolic disorder

17 September 2017

1 reference

0 references

1 reference

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27480090%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Jakob R. Passweg

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27480090%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

author name string

Matyas Ecsedi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27480090%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Jörg Schmohl

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27480090%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Robert Zeiser

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27480090%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Beatrice Drexler

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27480090%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Jörg Halter

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27480090%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Michael Medinger

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27480090%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Justus Duyster

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27480090%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Lothar Kanz

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27480090%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Jürgen Finke

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27480090%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Wolfgang Bethge

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27480090%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

language of work or name

1 reference

2 August 2016

1 reference

17 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27480090%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

volume

95

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27480090%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

page(s)

1627-1636

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27480090%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27480090%20AND%20SRC:MED&resulttype=core&format=json

Allogeneic stem cell transplantation after reduced-intensity conditioning in patients with myelofibrosis: a prospective, multicenter study of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation

11 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00277-016-2758-Z

Indication and management of allogeneic stem cell transplantation in primary myelofibrosis: a consensus process by an EBMT/ELN international working group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-016-2758-Z

Standard graft-versus-host disease prophylaxis with or without anti-T-cell globulin in haematopoietic cell transplantation from matched unrelated donors: a randomised, open-label, multicentre phase 3 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-016-2758-Z

Allogeneic haematopoietic cell transplantation for myelofibrosis in 30 patients 60-78 years of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-016-2758-Z

Impact of allogeneic stem cell transplantation on survival of patients less than 65 years of age with primary myelofibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-016-2758-Z

The impact of antithymocyte globulin on short-term toxicity after allogeneic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-016-2758-Z

Mechanisms of action of antithymocyte globulin: T-cell depletion and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-016-2758-Z

Lower dose anti-thymocyte globulin for GvHD prophylaxis results in improved survival after allogeneic stem cell transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-016-2758-Z

A Pilot Study of the Telomerase Inhibitor Imetelstat for Myelofibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-016-2758-Z

Acute graft-versus-host disease: a bench-to-bedside update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-016-2758-Z

Apparent hemolysis following intravenous antithymocyte globulin treatment in a patient with marrow failure and a paroxysmal nocturnal hemoglobinuria clone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-016-2758-Z

Antilymphocyte Globulin for Prevention of Chronic Graft-versus-Host Disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-016-2758-Z

JAK inhibition with ruxolitinib as pretreatment for allogeneic stem cell transplantation in primary or post-ET/PV myelofibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-016-2758-Z

JAK2 inhibitors do not affect stem cells present in the spleens of patients with myelofibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-016-2758-Z

Mechanisms of disease: mechanisms and clinical implications of cholestasis in sepsis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-016-2758-Z

10.1007/S00277-016-2758-Z

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27480090%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

1 reference